Ectopic ULBP2 Is Associated with Decreased NKG2D Expression in CD8<sup>+</sup> T Cells Under T Cell-Modulatory Conditions in a Murine Tumor Model
UL16-binding protein 2 (ULBP2), a ligand for the activating receptor NKG2D, plays a dual role in tumor immunity, promoting immune activation or suppression, depending on the context. To investigate its impact on CD4<sup>+</sup>CD25<sup>+</sup> T cell-targeted immunotherapies,...
Saved in:
Main Authors: | Yasuhiko Teruya, Kosuke Yamaguchi, Kohei Yamane, Naomi Miyake, Yuji Nakayama, Takafumi Nonaka, Hiroki Chikumi, Akira Yamasaki |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2025-06-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/14/12/893 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Increased proliferative response of highly differentiated CD57<sup>+</sup>NKG2C<sup>+</sup>NK cells expressing NKG2A
by: N. A. Alekseeva, et al.
Published: (2024-09-01) -
INHIBITION OF THE NKG2D ACTIVATING RECEPTOR EXPRESSION ON CYTOTOXIC LYMPHOCYTES BY RECOMBINANT MICA PROTEIN
by: E. V. Abakushina, et al.
Published: (2017-01-01) -
POTENTIAL USAGE OF NK CELLS AND NKG2D-POSITIVE LYMPHOCYTES AS TARGETS IN THERAPY OF CROHN’S DISEASE
by: E. A. Shulenina, et al.
Published: (2017-08-01) -
Epigenetic modulation elicits an NK cell-mediated immune response in urothelial carcinoma
by: Himani Kumari, et al.
Published: (2025-06-01) -
RAE1-armoured DC vaccine boosts NKG2D-CAR-T cells elicited anti-solid tumour treatment
by: Yixin Duan, et al.
Published: (2025-09-01)